Last reviewed · How we verify

NCT03461029

Bispectral Index Monitoring During Anesthesiologist - Directed Sedation in Scheduled Colonoscopies

Completed Last updated 9 March 2018
What this trial tests

trial testing BIS monitor in Colonoscopy in 196 participants. Completed in 20 February 2018.

Timeline
30 January 2016
Primary endpoint
30 December 2017
20 February 2018

Quick facts

Lead sponsorHospital Galdakao-Usansolo
StatusCompleted
Study typeOBSERVATIONAL
Enrollment196
Start date30 January 2016
Primary completion30 December 2017
Estimated completion20 February 2018
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Hospital Galdakao-Usansolo

Who can join

Adults 18 to 80, any sex, with Colonoscopy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to establish and identify the level of sedation that is performed in the endoscopy rooms of Galdakao Hospital. To do this, the investigators used the BIS monitoring system, which obtains objective values in real time from the anesthesia performed. The monitoring is completed with basic parameters validated by European guidelines (heart rate, blood pressure, oxygen saturation and respiratory rate), capnography and Ramsay sedation scale, widely validated for use outside the operating room. The main work hypothesis was that in at least 10% of the patients BIS values compatible with moderate or deep sedation would be obtained (BIS \<65).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of BIS monitor

Trials testing the same drug.

Other recruiting trials for Colonoscopy

Currently open trials in the same condition.

Other Hospital Galdakao-Usansolo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03461029.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing